The primary aim was to investigate whether there is an incremental change of resistin from healthy to diabetic patients, analyzing its association with the clinical indicators – IRI, HOMA index; whether it refelects the oxidative stress - evaluated by the level of urinary isoprostanes, or is more closely related to insulin resistance and immunoreactive insulin. This evidence concerns the gene INS and Insulin resistance.